Sono-Tek (SOTK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
10 Jul, 2025Executive summary
Net sales rose 2% year-over-year to $5.13M, driven by strong shipments to the Alternative/Clean Energy market and a $2.95M repeat order for advanced solar applications.
Gross profit increased 9% to $2.7M, with gross margin expanding to 52% from 49% due to favorable product mix and higher-margin U.S. sales.
Operating income grew to $483K, up 103% year-over-year, reflecting higher gross profit and reduced operating expenses.
Net income rose 47% year-over-year to $485K, with EPS at $0.03 versus $0.02 in the prior year period.
Maintains a strong balance sheet with no debt and $10.9M in cash and marketable securities as of May 31, 2025.
Financial highlights
Net sales: $5.13M, up 2% year-over-year.
Gross profit: $2.7M, up 9% year-over-year; gross margin 52%.
Operating income: $483K, up 103% year-over-year.
Net income: $485K, up 47% year-over-year.
EPS: $0.03 basic and diluted, up from $0.02.
Outlook and guidance
Management expects continued variability in order flow and shipments due to high ASP platform machine orders.
Expects continued revenue growth and profitability in the first half of FY 2026, supported by a $7.5M backlog.
Full-year revenue outlook is cautious, anticipating relatively flat growth due to uncertainty from policy shifts in clean energy incentives and tariffs.
Anticipates sales growth in medical and alternative energy markets, with a rebound in industrial market sales expected in the second quarter of fiscal 2026.
Backlog at May 31, 2025 was $7.48M, down 14% sequentially from February 28, 2025.
Latest events from Sono-Tek
- Leadership in ultrasonic coatings, global reach, and scalable solutions drive growth.SOTK
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - 4% revenue growth to $20.5M, $1.27M net income, and strong backlog support near-term growth.SOTK
Q4 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record backlog and high-value system sales drive growth in clean energy and tech markets.SOTK
21st Virtual Investor Summit Microcap Event13 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor change, executive pay, and board governance.SOTK
Proxy Filing1 Dec 2025 - Net income surged on 40% sales growth, led by medical and clean energy demand.SOTK
Q1 202513 Jun 2025